These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 5650194)

  • 21. Massive myoglobinuria precipitated by halothane and succinylcholine in a member of a family with elevation of serum creatine phosphokinase.
    Moore WE; Watson RL; Summary JJ
    Anesth Analg; 1976; 55(5):680-2. PubMed ID: 987723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum creatine phosphokinase and pyruvate kinase in neuromuscular disorders and Duchenne dystrophy carriers.
    Seay AR; Ziter FA; Wu LH; Wu JT
    Neurology; 1978 Oct; 28(10):1047-50. PubMed ID: 570660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Genetics and clinical types of progressive muscular dystrophy; creatine kinase and myoglobin as biochemical indices of the disease].
    Miyoshi K; Kawai H; Sasaki H; Iwaasa M; Yagita M; Ise H; Kondo A; Hiasa M
    Nihon Rinsho; 1977 Nov; 35(11):3891-6. PubMed ID: 599669
    [No Abstract]   [Full Text] [Related]  

  • 24. Serum creatine kinase BB and MM concentrations determined by radioimmunoassay in neuromuscular disorders.
    Zweig MH; Adornato B; Van Steirteghem AC; Engel WK
    Ann Neurol; 1980 Apr; 7(4):324-8. PubMed ID: 7377757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dilution effect on serum creatine kinase in carriers of Duchenne muscular dystrophy.
    Simpson AC; Holmes D; Pennington RJ
    Ann Clin Biochem; 1979 Jan; 16(1):54-5. PubMed ID: 420506
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum myoglobin in muscular dystrophy.
    Kagen LJ; Moussavi S; Miller SL; Tsairis P
    Muscle Nerve; 1980; 3(3):221-6. PubMed ID: 7374673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Duchenne muscular dystrophy carrier detection using logistic discrimination: serum creatine kinase, hemopexin, pyruvate kinase, and lactate dehydrogenase in combination.
    Percy ME; Andrews DF; Thompson MW
    Am J Med Genet; 1982 Sep; 13(1):27-38. PubMed ID: 7137219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Progressive muscular dystrophy].
    Sugita H
    No To Shinkei; 1986 Feb; 38(2):111-20. PubMed ID: 3516182
    [No Abstract]   [Full Text] [Related]  

  • 29. Variability of serum creatine phosphokinase activity in normal women and carriers of the gene for Duchenne muscular dystrophy.
    Perry TB; Fraser FC
    Neurology; 1973 Dec; 23(12):1316-23. PubMed ID: 4796611
    [No Abstract]   [Full Text] [Related]  

  • 30. [Study on progressive muscular dystrophy. 1. Influence of the various drugs on serum enzyme activity and the degree of disability].
    Kanno M; Annaka S; Sato N; Shinoda M
    Iryo; 1968 Dec; 22(12):1364-71. PubMed ID: 5717702
    [No Abstract]   [Full Text] [Related]  

  • 31. [Muscle creatine phosphokinase isoenzymes in progressive muscular dystrophy].
    Cao A; De Virgiliis S; De Marco A; Coppa G
    Riv Clin Pediatr; 1968; 81(4):504-8. PubMed ID: 5759722
    [No Abstract]   [Full Text] [Related]  

  • 32. Anaesthesia and serum creatine phosphokinase levels in patients with Duchenne's pseudohypertrophic muscular dystrophy.
    Richards WC
    Anaesth Intensive Care; 1972 Nov; 1(2):150-3. PubMed ID: 4668562
    [No Abstract]   [Full Text] [Related]  

  • 33. Absence of correlation between skewed X inactivation in blood and serum creatine-kinase levels in Duchenne/Becker female carriers.
    Sumita DR; Vainzof M; Campiotto S; Cerqueira AM; Cánovas M; Otto PA; Passos-Bueno MR; Zatz M
    Am J Med Genet; 1998 Dec; 80(4):356-61. PubMed ID: 9856563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum enzymes in disease of skeletal muscle.
    Rosalki SB
    Clin Lab Med; 1989 Dec; 9(4):767-81. PubMed ID: 2686911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of serum creatine phosphokinase in genetic counseling for Duchenne muscular dystrophy. I. Analysis of results from 29 studies.
    Gale AN; Murphy EA
    J Chronic Dis; 1978 Feb; 31(2):101-9. PubMed ID: 659567
    [No Abstract]   [Full Text] [Related]  

  • 36. [Creatine phosphokinase activities in various skeletal muscles in a case of progressive muscular dystrophy (Duchenne type). Enzymatic measurements at autopsy].
    Araki S; Inokuchi T; Narazaki T
    Igaku To Seibutsugaku; 1967 Oct; 75(4):145-8. PubMed ID: 5627037
    [No Abstract]   [Full Text] [Related]  

  • 37. The significance of changes in the blood serum electrolytes in the detection of heterozygous carriers of Duchenne myopathy.
    Grinio LP
    Sov Genet; 1974 Mar; 7(12):1596-9. PubMed ID: 4827770
    [No Abstract]   [Full Text] [Related]  

  • 38. [Serum creatine phosphokinase in various muscular diseases seen in the field of orthopedic surgery].
    Iwamoto A
    Igaku Kenkyu; 1969 May; 39(2):108-21. PubMed ID: 5389323
    [No Abstract]   [Full Text] [Related]  

  • 39. Duchenne muscular dystrophy carrier detection using logistic discrimination: serum creatine kinase and hemopexin in combination.
    Percy ME; Andrews DF; Thompson MW
    Am J Med Genet; 1981; 8(4):397-409. PubMed ID: 7246612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carrier detection in X-linked muscular dystrophy.
    Walton JN
    J Genet Hum; 1969 Oct; 17(3):497-510. PubMed ID: 5387424
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.